Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05468697
Title A Study of Belzutifan (MK-6482) in Combination With Palbociclib Versus Belzutifan Monotherapy in Participants With Advanced Renal Cell Carcinoma (MK-6482-024)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ISR | AUS

Facility Status City State Zip Country Details
Georgetown University Medical Center ( Site 1002) RECRUITING Washington District of Columbia 20007 United States Details
Beth Israel Deaconess Medical Center-Cancer Clinical Trials Office ( Site 1001) RECRUITING Boston Massachusetts 02215 United States Details
Huntsman Cancer Institute-HCI Clinical Trials Office ( Site 1004) RECRUITING Salt Lake City Utah 84112 United States Details
Macquarie University-MQ Health Clinical Trials Unit ( Site 2001) RECRUITING Macquarie University New South Wales 2109 Australia Details
Westmead Hospital-Department of Medical Oncology ( Site 2006) RECRUITING Westmead New South Wales 2145 Australia Details
Frankston Hospital-Oncology and Haematology ( Site 2005) RECRUITING Frankston Victoria 3199 Australia Details
One Clinical Research ( Site 2008) RECRUITING Nedlands Western Australia 6009 Australia Details
Emek Medical Center-oncology ( Site 3003) RECRUITING Afula 1834111 Israel Details
Rambam Health Care Campus-Oncology ( Site 3000) RECRUITING Haifa 3109601 Israel Details
Shaare Zedek Medical Center-Oncology ( Site 3002) RECRUITING Jerusalem 9103102 Israel Details
Rabin Medical Center-Oncology ( Site 3004) RECRUITING Petah Tikva 4941492 Israel Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field